These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19658234)

  • 1. Making the top-tech list.
    DerGurahian J
    Mod Healthc; 2009 Jul; 39(29):26-8. PubMed ID: 19658234
    [No Abstract]   [Full Text] [Related]  

  • 2. Usable health IT for physicians. Smart point-of-care and comparative effectiveness research form the true basis for meaningful use.
    Silva J; Seybold N; Ball M
    Healthc Inform; 2010 Jul; 27(7):40-3. PubMed ID: 20666183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spending limited health care dollars on what works best: the promise of comparative effectiveness research.
    Stein J
    N C Med J; 2010; 71(3):265-6. PubMed ID: 20681501
    [No Abstract]   [Full Text] [Related]  

  • 4. American Recovery and Reinvestment Act: making hospitals technologically advanced.
    GHA Today; 2009; 53(2):8-9. PubMed ID: 19862861
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effectiveness. Federal government's push for more data to benefit supply chain.
    Aston G
    Mater Manag Health Care; 2010 Apr; 19(4):22-5. PubMed ID: 20464853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How a unique provision in the American Recovery and Reinvestment Act set a foundation for the Patient-Centered Outcomes Research Institute.
    Selby J; Slutsky J
    J Comp Eff Res; 2014 Nov; 3(6):565-6. PubMed ID: 25494560
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effectiveness research: so far, so good.
    Wilensky GR
    Healthc Financ Manage; 2010 Nov; 64(11):34, 36. PubMed ID: 21061815
    [No Abstract]   [Full Text] [Related]  

  • 8. American Recovery and Reinvestment Act investments in data infrastructure.
    O'Day B; Kieffer T; Forrestal S; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):591-600. PubMed ID: 25494565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise and future of comparative effectiveness research.
    Clancy CM
    J Nurs Care Qual; 2010; 25(1):1-4. PubMed ID: 20010250
    [No Abstract]   [Full Text] [Related]  

  • 10. One-on-One with KLAS President Adam Gale. Gale discusses a HITECH buying frenzy that wasn't, & why Epic's page of the Mid-Term Performance Review makes competitors green with envy. Interviewed by Anthony Guerra.
    Gale A
    Healthc Inform; 2009 Sep; 26(9):suppl 11-2. PubMed ID: 19813568
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effectiveness.
    Aston G
    Trustee; 2010 Jan; 63(1):13-4, 19-21. PubMed ID: 20143663
    [No Abstract]   [Full Text] [Related]  

  • 12. An evaluation of recent federal spending on comparative effectiveness research: priorities, gaps, and next steps.
    Benner JS; Morrison MR; Karnes EK; Kocot SL; McClellan M
    Health Aff (Millwood); 2010 Oct; 29(10):1768-76. PubMed ID: 20921474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness. An idea whose time has finally come.
    Sipkoff M
    Manag Care; 2009 Apr; 18(4):14-6, 19-21. PubMed ID: 19472562
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of comparative effectiveness on U.S. healthcare providers.
    Bigalke JT
    Healthc Financ Manage; 2009 Oct; 63(10):74-8. PubMed ID: 19810656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments on 'Comparative effectiveness research: Policy context, methods development and research infrastructure'.
    Morton SC
    Stat Med; 2010 Aug; 29(19):1989-90; discussion 1996-7. PubMed ID: 20683889
    [No Abstract]   [Full Text] [Related]  

  • 16. 'Huge potential' for EHRs and comparative effectiveness.
    McKinney M
    Hosp Health Netw; 2010 Apr; 84(4):41-2. PubMed ID: 20464840
    [No Abstract]   [Full Text] [Related]  

  • 17. The dollars & sense of health information technology (HIT) funding.
    J Ky Med Assoc; 2009 Nov; 107(11):435-7. PubMed ID: 19999859
    [No Abstract]   [Full Text] [Related]  

  • 18. The relevance of international studies to informed pharmacoeconomics and health policy decisions.
    Lyles A
    Clin Ther; 2010 Jan; 32(1):106-7. PubMed ID: 20171416
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effectiveness and real-world evidence.
    Leonard DT
    Am J Manag Care; 2010 Jun; 16(6):410-1. PubMed ID: 20560684
    [No Abstract]   [Full Text] [Related]  

  • 20. Meaningful use. What does it mean for healthcare organizations?
    Hoehn BJ
    J Healthc Inf Manag; 2010; 24(1):10-2. PubMed ID: 20077918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.